Načítá se...
Immune cells: more than simple carriers for systemic delivery of oncolytic viruses
Oncolytic virotherapy on its own has numerous drawbacks, including an inability of the virus to actively target tumor cells and systemic toxicities at the high doses necessary to effectively treat tumors. Addition of immune cell-based carriers of oncolytic viruses holds promise as a technique in whi...
Uloženo v:
| Vydáno v: | Oncolytic Virother |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Dove Medical Press
2014
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4354653/ https://ncbi.nlm.nih.gov/pubmed/25767789 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OV.S47143 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|